Agios Pharmaceuticals AGIO Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's operating lease ROU assets?
- Agios Pharmaceuticals (AGIO) reported operating lease ROU assets of 5.7% in Q1 2026.
- How has Agios Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Agios Pharmaceuticals's operating lease ROU assets decreased by 0.0% year-over-year, from 5.7% to 5.7%.
- What is the long-term trend for Agios Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's operating lease ROU assets has grown at a -98.5% compound annual growth rate (CAGR), from 8,466,100,000% to 5.7%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.